Health Care Distributors Industry ESG Material Mapping

HC-DI-510a.1Description of efforts to minimize conflicts of interest and unethical business practices

HC-DI-510a.2Total amount of monetary losses as a result of legal proceedings associated with bribery, corruption, or other unethical business practices

HC-DI-260a.1Description of methods and technologies used to maintain traceability of products throughout the distribution chain and prevent counterfeiting

HC-DI-260a.2Discussion of due diligence process to qualify suppliers of drug products and medical equipment and devices

HC-DI-260a.3Discussion of process for alerting customers and business partners of potential or known risks associated with counterfeit products

HC-DI-110a.1Payload fuel economy

HC-DI-110a.2Description of efforts to reduce the environmental impact of logistics

HC-DI-410a.1Discussion of strategies to reduce the environmental impact of packaging throughout its lifecycle

HC-DI-410a.2Amount (by weight) of products accepted for take-back and reused, recycled, or donated

HC-DI-250a.1Total amount of monetary losses as a result of legal proceedings associated with product safety

HC-DI-250a.2Description of efforts to minimize health and safety risks of products sold associated with toxicity/chemical safety, high abuse potential, or delivery